NL
DE
About Radboudumc
Our strategy
Artificial Intelligence (AI) for health
News
Radboudumc partners with Annalise.ai
27 November 2024
Radboudumc has partnered with Annalise.ai, an Australian developer of medical AI applications. As part of this, Radboudumc will use Annalise technology to assess CT scans of the brain and chest X-rays. Radboudumc is also starting a multi-year research program to evaluate the impact of AI applications on medical practice.
For more information, read the full press release on Annalise’s website.
-
Want to know more about these subjects? Click on the buttons below for more news.
Related news items
.aspx?width=800&height=534&ext=.jpg&type=BlockColumn1Zoom1)
Aiosyn and Radboudumc are the first in the Netherlands to implement AI in the clinical pathology workflow Digital pathology slides will be screened with a quality control algorithm
4 April 2022 Aiosyn, a company that develops AI-powered computational pathology analysis for clinical diagnostics, and the department of pathology of Radboudumc, will collaborate to implement an algorithm for quality control of digitized histopathology tissue slides. read more
Thomas van den Heuvel wins Stairway to Impact Award for safer pregnancies using AI Award for safer pregnancies using AI
1 December 2021Radboudumc researcher Thomas van den Heuvel receives the Stairway to Impact Award from Dutch Research Council NWO. He receives this prize for the development of the BabyChecker, a smartphone application that allows midwives to make ultrasounds during pregnancies.
read more
TropIQ seeks new mosquito repellents
21 September 2021 TropIQ Health Sciences, a Radboudumc spin-off, has received a 1.3 million USD grant from the Bill & Melinda Gates Foundation to track down new mosquito repellents. read more
